STUDY OF BIOLOGICALLY ACTIVE COMPOUNDS BY CATALYTIC REACTIONS

Catalytic processes, by contrast, minimize byproducts and often allow for the use of renewable starting materials, aligning with the principles of green chemistry . The use of heterogeneous catalysts, which can be easily recovered and reused, has gained traction in the production of biologically active natural products. The significance of catalysis in this domain lies in its ability to enhance both the yield and the selectivity of target molecules. For instance, the development of antibiotics, anticancer agents, and antiviral drugs often hinges on the precise introduction of functional groups or stereocenters, which catalytic methods can achieve with remarkable precision. Taxol, a potent chemotherapeutic agent, exemplifies this: its synthesis has been optimized using catalytic steps to improve scalability and reduce costs. Beyond synthesis, catalysis facilitates the study of these compounds by enabling the rapid generation of analogues for testing, thus accelerating drug discovery and development. This interplay between synthesis and study underscores the dual role of catalysis as both a practical tool and a scientific enabler.